Nearly one in three adults with depression won’t get better on standard oral antidepressants, according to Johnson & Johnson’s clinical data behind Spravato’s FDA approval. That statistic isn’t just a number. It’s the reason esketamine therapy Arizona clinics exist, and why so many people search for esketamine therapy near me after years of medications that never quite worked.
Spravato esketamine is a nasal spray derived from ketamine, and the FDA approved it specifically for adults whose depression hasn’t responded to at least two other medications. Unlike traditional antidepressants, which can take six to eight weeks to show any effect, esketamine works on a different brain pathway. It targets glutamate instead of serotonin, so you might notice a shift in depressive symptoms within 24 hours rather than months.
That speed matters. If you’ve spent years cycling through one oral antidepressant after another, watching a treatment finally move the needle can change how you think about recovery altogether.
Not everyone with depression qualifies for esketamine for treatment-resistant depression. It’s built for adults with treatment resistant depression, sometimes called treatment resistant depression (TRD), meaning two or more prior medications haven’t worked for you. Getting here usually starts with a thorough psychiatric evaluation, where a provider walks through your treatment history, current symptoms, and overall health before recommending next steps.
You might also wonder how esketamine compares to ketamine infusions. Both work on similar brain receptors, but esketamine is FDA-approved, self-administered under supervision, and typically covered differently by insurance.
Sessions at a Spravato treatment center follow a consistent rhythm. You self-administer the nasal spray under medical supervision, then stick around for roughly two hours while a clinician checks your blood pressure and watches for side effects like dissociation or dizziness. Most patients experience those effects fading well before they head home.
Treatment isn’t a one-time visit, either. Most esketamine treatment center in Arizona programs start you on twice-weekly sessions for the first month, tapering off as your symptoms improve. Medication management with your existing antidepressant medication usually continues alongside esketamine rather than replacing it, at least early on.
Cost is probably your first question, and it’s a fair one. Many insurance plans now cover esketamine for diagnosed TRD, though prior authorization is common. Ask upfront how a treatment center handles billing, because the process varies more than you’d expect from one practice to the next.
Location matters too. An Arizona spravato therapy program close to home makes those twice-weekly early sessions far more manageable than a long drive across town. Look for a center with psychiatric providers on staff, not just technicians running the room, since your dosing decisions should reflect your full mental health history, not a checklist.
Scottsdale TMS built its esketamine program around the idea that your mental health care should adapt to you, not the other way around. The team works alongside your existing psychiatrist when possible, coordinates directly with insurance plans, and treats esketamine as one tool among several, including TMS, for people who’ve tried traditional medications without lasting results. If oral antidepressants haven’t worked for you, a conversation with Scottsdale TMS is a reasonable next step, not a last resort.
Dr. Vines has practiced psychiatry in Arizona for for over 25 years and has experience working with diverse populations that include children, adolescents, adults, geriatrics, SMI patients, and the chemically dependent.
August 14, 2026
